The current study tests the hypothesis that chronic atrophic gastritis from hypochlorhydria in the gastrindeficient mouse predisposes the stomach to gastric cancer. Gross morphology and histology of 12-month-old wildtype (WT), gastrin-deficient (GÀ/À) and somatostatindeficient (SOMÀ/À) mice were examined. Parietal and G cells, Ki67, TUNEL, villin and MUC2 expression were analysed by immunohistochemistry. RUNX3 and STAT3 expression was analysed by Western blot. Anchorageindependent growth was determined by cell cluster formation in soft agar. Compared to the WT and SOMÀ/À mice, hypochlorhydric GÀ/À mice developed parietal cell atrophy, significant antral inflammation and intestinal metaplasia. Areas of metaplasia within the GÀ/ À mouse stomach showed decreased RUNX3 expression with elevated MUC2 and villin expression. Cells isolated from the tumor grew in soft agar. However, the cells isolated from WT, nontransformed GÀ/À and SOMÀ/À gastric tissue did not form colonies in soft agar. Consistent with elevated antral proliferation, tumor tissue isolated from the GÀ/À mice showed elevated phosphorylated STAT3 expression. We then examined the mechanism by which STAT3 was constitutively expressed in the tumor tissue of the GÀ/À mice. We found that IFNc expression was also significantly higher in the tumor tissue of GÀ/À mice compared to WT and SOMÀ/À animals. To determine whether STAT3 was regulated by IFNc, MKN45 cells were cocultured with IFNc or gastrin. IFNc significantly stimulated phosphorylation of STAT3 in the MKN45 cell line, but not gastrin. Therefore, we show here that in the hypochlorhydric mouse stomach, the chronic gastritis, atrophy, metaplasia, dysplasia paradigm can be recapitulated in mice. Moreover, neoplastic transformation of the antral gastric mucosa does not require gastrin.
Introduction
Gastrin, a hormone secreted from antral gastrinexpressing cells (G -cells), was first characterized by its ability to stimulate acid secretion. In addition to its role in the regulation of acid secretion, gastrin also stimulates proliferation of the fundic mucosa (Johnson, 1977; Wang et al., 1996) . Hypergastrinemia in response to Helicobacter pylori infection is believed to be a factor influencing the development of gastric cancer (Blaser and Parsonnet, 1994) . Recently, genetically engineered mouse models that overexpress gastrin peptide have permitted a more concise analysis of the role of gastrin in gastric proliferation and differentiation. The insulingastrin (INS-GAS) transgenic mouse overexpresses the gastrin gene in b cells of the pancreas due to expression from the insulin promoter (Wang et al., 2000) . As expected, the resulting hypergastrinemia in the INS-GAS mouse stimulates proliferation of the fundic gastric mucosa. By 20 months, these transgenic mice spontaneously develop cancer in the gastric fundus (Wang et al., 2000; Fox et al., 2003) . Infection with H. felis accelerates the progression to gastric cancer in these mice such that cancer is detected within 8 months (Wang et al., 2000) . Thus, studies using INS-GAS mice suggest that Helicobacter infection synergizes with hypergastrinemia to accelerate malignant transformation in the acid-secreting portion of the stomach. However, there are several mouse models that develop gastric cancer independently of Helicobacter infection. These murine models include genetically engineered mice in which the TFF1, Smad4 or RUNX3 genes have been deleted (Lefebvre et al., 1996; Xu et al., 2000; Li et al., 2002) . In addition, a mutated form of the IL-6 receptor subunit gp130 757F/F resulting in constitutive activation of STAT3 has also been found to cause gastric cancer in the antrum (Judd et al., 2004) . Interestingly, measurement of plasma gastrin levels in gp130 757F/F mice showed that these animals are hypogastrinemic (Judd et al., 2004) .
Mice that lack the gastrin gene or the gastrin/ cholecystokinin-B receptor have altered gastric mucosal architecture and differentiation (Nagata et al., 1996; Koh et al., 1997; Friis-Hansen et al., 1998) . Gastrin and gastrin receptor-null mice exhibit reduced numbers of enterochromaffin-like cells and an expansion of mucous and surface epithelial cells (Nagata et al., 1996; Koh et al., 1997; Friis-Hansen et al., 1998) . In addition, gastrin-deficient (GÀ/À) mice not only develop hypochlorhydria and decreased parietal cell numbers over time, but the parietal cells themselves are immature and poorly responsive to administration of the major acid secretagogues including gastrin, histamine and acetylcholine (Friis-Hansen et al., 1998) . Our prior studies in the GÀ/À mouse revealed that these animals also develop severe inflammation and mucous gland metaplasia as a consequence of bacterial overgrowth (Zavros et al., 2002a) . The initial histologic changes observed in the GÀ/À mice are similar to the precursor lesions progressing to gastric cancer in human subjects originally described by Correa (1992) . However, whether the GÀ/À mouse develops gastric cancer independent of Helicobacter infection has not been investigated. Therefore, we examined the effect of chronic atrophic gastritis from hypochlorhydria in the GÀ/À mouse.
Results

Spontaneous development of gastric tumors in GÀ/À mouse stomachs
A recent study showed that gastric cancer develops in mice in response to a sustained proinflammatory stimulus (Judd et al., 2004) . In addition to alterations in the IL-6 cytokine pathway that result in increased STAT3 and loss of Erk-AP1 activation, the mice are hypogastrinemic (Judd et al., 2004) . We have recently found that hypogastrinemic mice develop gastritis due to bacterial overgrowth in hypochlorhydric stomachs (Zavros et al., 2002a) . To evaluate the long-term effects of gastrin deficiency and hypoacidity, these mice were evaluated at 12 months of age and compared to agematched wild-type (WT) mice. To examine the longterm effects of hypergastrinemia and hyperacidity in the absence of inflammation on the gastric mucosa, somatostatin-deficient (SOMÀ/À) mice were also evaluated at 12 months of age. Unlike the GÀ/À mice, SOMÀ/À mice were hypergastrinemic and hyperacidic due to loss of the somatostatin inhibitory pathway on gastrin (Table 1) . Examination of GÀ/À mouse stomachs at 12 months revealed the presence of macroscopically visible tumors in six out of the 10 mice examined, while stomachs from all 10 WT mice exhibited normal gastric morphology (Figure 1 ). All six of the tumors observed were in the antral region of the GÀ/À mouse stomach (Table 1) . In contrast, all 10 SOMÀ/À mice developed a thickened fundus (Figure 1c ), but no tumors were observed macroscopically (Table 1) . Stomachs from the SOMÀ/À mice were significantly heavier than those of the WT and GÀ/À mice consistent with the hyperplastic fundus (Figure 1d) . Analysis of the gastric fluid for hydrogen ion concentration confirmed that GÀ/À mice were hypochlorhydric (Table 1) , whereas the SOMÀ/À animals were hyperacidic relative to the age-matched WT controls (Table 1) .
Chronic atrophic gastritis in the 12-month hypochlorhydric GÀ/À mice Since the gross morphology showed that 60% of the GÀ/À mice developed gastric tumors, to determine whether these mice exhibited the predicted precursor lesions, that is, atrophy and inflammation, the fundi and antrums were examined histologically. Hematoxylin and eosin (H&E) stains revealed atrophy of the parietal cell layer in the gastric glands of GÀ/À mice ( Figure 2a ). Morphometric analysis confirmed a significant loss of parietal cells in GÀ/À mice (Table 1) . Accompanying the loss of parietal cells was an expansion of the surface mucous cell layer in GÀ/À fundi. The expansion of the gastric mucous cell layer was confirmed by the intense staining of gastric mucins with PAS/alcian blue ( Figure 2b ).
Histologic examination of the antrums revealed inflammatory cells infiltrating the mucosa of the GÀ/À mouse stomachs. There was no significant change in the mononuclear cell infiltrate consisting of a mixture of lymphocytes, plasma cells and histocytes in either the antral or fundic tissues of WT, SOMÀ/À and GÀ/À mice (data not shown). However, there was a significant increase in the number of antral polymorphonuclear neutrophils (PMNs) (Figure 3a) . Although there was a trend toward greater numbers of fundic PMNs, the change was not statistically significant (data not shown). Since chronic atrophic gastritis is characterized by the presence of T lymphocytes, we stained the sections for CD4 þ cells and quantified the numbers by morphometry. There was no difference in the fundic CD4 þ cell number between WT, SOMÀ/À and GÀ/À mice (data not shown). However, analysis revealed greater numbers of T cells in the gastric antrums of GÀ/À mice compared to WT and SOMÀ/À mice (Figure 3b ).
To determine if there were differences in the proliferative and apoptotic rates between the WT, (Figure 4 ). GÀ/À mice showed more Ki67-positive cells in the fundic neck region than the WT animals ( Figure 4a ). Although immunohistochemical stains clearly showed a decrease in the parietal cell layer in GÀ/À mice, there was a compensatory increase in the surface mucous cell layer (Figure 2a and b) . The increase in the number of parietal cells in the SOMÀ/À mice was confirmed by morphometric analysis (Table 1) . Consistent with the increased number of parietal cells, the number of Ki67-positive neck cells was elevated (Figure 4a ).
Further evaluation of the antrums revealed the presence of epithelial cell proliferation in both the GÀ/À and SOMÀ/À mice. Indeed, morphometric analysis to quantify the Ki67-positive cells revealed a significantly greater number of proliferating cells in both the fundi and antrums of both the GÀ/À and SOMÀ/À mice compared to the WT animals ( Figure 4b ). Nevertheless, histologic examination revealed a smaller fundus and hyperplastic antrum in the GÀ/À mice, suggesting that changes in the proliferative rate were not sufficient to explain the histologic features. Therefore, the extent and location of apoptotic cells was examined by TUNEL ( Figure 4) . The TUNEL assay revealed that there were significantly more apoptotic cells in the fundic glands of the GÀ/À mice compared to both WT and SOMÀ/À mice. In addition, there was significantly less apoptosis in the antrums of GÀ/À mice ( Figure 4b ). Thus, although both the proliferative and apoptotic rates were elevated in the SOMÀ/À mice, the apoptotic rate in the fundus of GÀ/À mice was much greater and correlated with the dramatic histologic changes observed despite increased proliferation. Moreover, the increase in TUNEL staining was located in the gastric glands, suggesting that the loss of parietal cells occurred by programmed cell death (Figure 4a ). In contrast to the GÀ/À mice, the TUNEL staining in the SOMÀ/À mice was located in the mucous cell layer rather than the glands, which was consistent with the glandular hyperplasia observed despite a higher apoptotic rate than the WT mice (Figure 4a and b).
Mucin and villin expression in the antrums of GÀ/À mice
Having established large differences in the apoptotic rate, we sought to define some of the molecular changes. Villin is normally expressed in the microvilli of the enterocyte and is expressed in the stomach during intestinal metaplasia (Bretscher and Weber, 1979) . Intestinal metaplasia in the stomach is thought to be an early indicator of progression toward neoplastic transformation (Osborn et al., 1988) . Compared to the normally weak villin expression in WT mice, strong villin staining was observed in adjacent areas of antral dysplasia in the GÀ/À mice ( Figure 5a and b). However, there was loss of villin immunostaining in the tumors of GÀ/À mice (data not shown) compared to the positive antral staining observed in the dysplastic tissue of the GÀ/À animals. Like villin, MUC2 expression in the stomach is a marker of intestinal metaplasia (Semino- Mora et al., 2003) . Therefore, we examined the tissue for MUC2 and found that the antral tissue from GÀ/À mice stained strongly for the intestinal mucin ( Figure 5c and d). Therefore, we concluded that adjacent to the antral tumor, metaplastic tissue expresses both villin and MUC2. To further evaluate the presence of malignant transformation, we examined the tissue for expression of the tumor suppressor gene RUNX3 (Li et al., 2002) . RUNX3 is a member of the RUNX transcription factor family that is capable of inducing apoptosis (Bae and Choi, 2004 ). An immunoblot comparing whole-cell extracts from WT, GÀ/À and SOMÀ/À mice revealed the presence of the 44 kDa RUNX3 protein in WT mice, reduced levels in antral metaplastic GÀ/À (GÀ/ÀM) tissue and the absence of RUNX3 protein in the antral GÀ/À tumors (Figure 7a and b). Hyperplastic fundic tissue from the SOMÀ/À mouse showed increased RUNX3 protein expression (Figure 7a and b). These results are consistent with the ability of RUNX3 to regulate apoptosis since RUNX3 was inactivated in the antral tumor where evidence of apoptosis was low.
STAT3 is constitutively activated in the GÀ/À tumor tissue
Altered expression or function of critical genes that regulate cell differentiation, proliferation and apoptosis often contributes to oncogenesis. Recently, it was reported that STAT3 is among the genes that are altered during cell transformation and cancer (Kanda et al., 2004) . Since constitutive activation of STAT3 with malignant cell proliferation occurs in a number of human cancer cell lines (Kanda et al., 2004) and mice (Judd et al., 2004) , we investigated the expression of phosphorylated STAT3 (p-STAT3) and phosphorylated STAT1 (p-STAT1) in the tissue of WT, SOMÀ/À, GÀ/ÀM and GÀ/ÀT mice. Western blot analysis revealed that compared to the WT, SOMÀ/À and GÀ/ÀM mouse tissue, expression of p-STAT3 and p-STAT1 was significantly greater in the GÀ/ÀT mice (Figure 8a and b) .
To address the cellular localization of STAT3 and STAT1, sections of WT and GÀ/ÀT stomachs were immunostained. Immunohistochemistry showed differential expression of STAT3 in the stomach tissue of WT and GÀ/À mice. In the WT mice, cytoplasmic STAT3 was localized to the base of the antral glands and occasionally was found in the surface pit cells. There was no significant p-STAT3 staining in the WT mice reflecting our Western blot analysis (Figure 8c ). STAT3 within the tumors of the GÀ/À mice was nuclear. However, in the tumor, p-STAT3 appeared to be within the mucous cells and localized within the cytoplasm (Figure 8c ). Interestingly, STAT1 is found in the cytoplasm of discrete endocrine appearing cells (data not shown). These data suggest that IFNg may exert its effects on different cell types via activation of either STAT1 or STAT3.
Since STAT3 is known to be induced by proinflammatory cytokines (Suter et al., 2001) , we examined whether IFNg levels were elevated in the tumors Since phosphorylated STAT3 and STAT1 were present in GÀ/À tumors, we tested directly whether gastrin inhibits STAT3 and STAT1 phosphorylation. The results showed that gastrin had no effect on either STAT3 or STAT1 phosphorylation alone, or in the presence of IFNg. This result supports the notion that the inflammation and production of the proinflammatory cytokines rather than gastrin induces STAT3 and STAT1 activation. To demonstrate that gastrin had an effect on MKN cells, p-ERK protein levels were determined and showed induction by gastrin. This result confirmed the presence of functional CCK-B/gastrin receptors on MKN cells as previously reported (Watson et al., 1989) . In addition, IFNg significantly induced ERK (Figure 10a and b) consistent with previous findings (Harigai et al., 2004 ).
Discussion
We show here that the phenotypic progression to gastric cancer observed in the GÀ/À mouse model is similar to the evolution of gastric cancer in humans initially described by Correa (1992) . In both human studies and the mouse model reported here, chronic inflammation results in atrophy of the fundic mucosa developing into intestinal metaplasia, dysplasia and eventually antral carcinoma (Correa, 1992) . In addition, we found that the development of gastric cancer in this model is independent of both Helicobacter infection and hypergastrinemia. Gastric neoplastic transformation was documented by histology, by a genetic marker and functionally by anchorage-independent growth. In addition, the presence of intestinal metaplasia adjacent to the dysplasia was documented by the expression of villin and MUC2. Therefore, we concluded that the GÀ/À mouse is an excellent model to study the development of gastric cancer from chronic atrophic gastritis. Chronic gastritis regardless of the etiology appears to be the most consistent early lesion leading to gastric cancer. The GÀ/À mouse is hypochlorhydric due to the (Koh et al., 1997; FriisHansen et al., 1998) . The stomach subsequently becomes inflamed (Zavros et al., 2002a) and over time the acidsecreting portion of the stomach atrophies. An important finding that we report here is the fact that the glandular atrophy is due to apoptosis rather than decreased proliferation. This result is consistent with the ability of H. pylori-induced inflammation to induce apoptosis (Peek, 2002; Cover et al., 2003) . Thus, regardless of whether the inflammatory trigger is H. pylori or bacterial overgrowth, the result is a convergent phenotype consisting of chronic inflammation and atrophic gastric glands. Genetically induced gastrin deficiency is unlikely to occur naturally. Nevertheless, this model underscores the potential transforming effects of chronic inflammation and the importance of gastrin in the normal homeostasis and glandular architecture of the stomach. A recent mouse model that develops antral gastric cancer is hypogastrinemic in response to overstimulation of the IL-6-STAT3 pathway (Judd et al., 2004) . Although the development of gastric cancer in those mice was rapid (3-4 months), that model also underscores the importance of inflammation in gastric cancer development.
The GÀ/À mouse is an important model that provides insight into the transforming effects of chronic inflammation. Inflammation is the likely cause of the oncogenic phenotype observed, given the strong correlation between elevated IFNg expression and constitutively activated STAT3 in the tumor tissue of the GÀ/À mice. STAT3 is activated by phosphorylation of a single tyrosine kinase residue (Tyr705) by a Janus kinase in response to cytokine stimulation (Darnell, 1997) . Under physiologic conditions, STAT3 activation normally lasts only for a few minutes (Bromberg et al., 1999) . In contrast, STAT3 that is constitutively activated contributes to oncogensis by preventing apoptosis while enhancing cell proliferation (Bowman et al., 2000; Mora et al., 2002) . This result is consistent with what was observed in the tumor tissue of the GÀ/À mice. In addition, studies have shown that IFNg strongly regulates STAT3 (Suter et al., 2001; Qing and Stark, 2004) . The in vitro regulation studies using MKN45 cells shown here revealed that while IFNg induced STAT3 phosphorylation, gastrin had no effect. There was strong correlation between elevated IFNg expression and STAT3 phosphorylation with tumor development in the GÀ/À mice. Thus, it is likely that inflammation in the GÀ/À mouse model rather than the direct effect of no gastrin plays a pivotal role in neoplastic transformation of the distal gastric mucosa. It has been shown that the hypergastrinemic INS-GAS transgenic mouse develops gastric cancer within 20 months in the absence of Helicobacter infection and 8 months in the presence of H. pylori inflammation (Wang et al., 2000) . The SOMÀ/À mouse that we studied here is hypergastrinemic, but hypergastrinemia alone was not sufficient to induce gastric cancer in the 12 months we followed these mice. Rather they showed significant hyperplasia. Thus, it is possible that fundic gland tumors would develop after a longer time period or that another factor, for example, H. pylori infection or high salt, is required to accelerate progression to cancer (Wang et al., 2000; Fox et al., 2003) . Nevertheless, it is clear that the hypergastrinemic state favors proliferation in the fundus rather than in the antrum.
In the GÀ/À mouse, villin expression was observed in areas of antral metaplasia. Villin expression increases in intestinal metaplasia and malignant human gastric mucosa (Osborn et al., 1988; Bacchi and Gown, 1991) . However, decreased villin expression was observed in the tumor tissue isolated from the GÀ/À mouse stomach. This is most likely due to the loss of intestinal-type differentiation as the tissue advances toward neoplasia. Variations in villin expression are often seen in Barrett's esophagus, a condition in which the normal esophageal epithelium is replaced by metaplastic columnar epithelium of the gastric or intestinal type (Barrett, 1957; Kumble et al., 1996) . In Barrett's esophagus, there is often a decrease or loss of villin expression in the presence of dysplasia or adenocarcinoma (Moore et al., 1994; Kumble et al., 1996) . Assuming that mature villin-expressing cells are Chronic gastritis in the gastrin-deficient mouse Y Zavros et al highly differentiated, it is not likely that these cells directly progress to adenocarcinoma but may indicate an enhanced proliferative state with a propensity to introduce mutations into the genome.
We found that there was complete loss of RUNX3 protein in the malignant tumors isolated from the GÀ/À mouse stomach. Our findings are consistent with Li et al. (2002) who showed complete loss of RUNX3 expression in a number of human gastric cancers and cell lines. Indeed, RUNX3 deficiency correlates with hyperplasia consistent with its tumor suppressor status (Li et al., 2002) . Transcriptional repression of RUNX3 is caused by promoter hypermethylation (Waki et al., 2003; Ku et al., 2004) . Recently, it was shown that environmental factors modulate gene expression (Waterland and Jirtle, 2003) . In particular, DNA methylation patterns are an important source of epigenetic regulation. While the effect of inflammation on RUNX3 promoter hypermethylation has not directly been examined, it is possible that inflammation might exert its effect on the genome through epigenetic rather than genetic mechanisms. Certainly, it has been shown that chronic inflammation is closely associated with hypermethylation of a number of genes in non-neoplastic tissue (Kang et al., 2003) . Moreover, the RUNX3 promoter was found to be hypermethylated in approximately 8% of chronic gastritis patients . In contrast to the GÀ/À mice, RUNX3 expression was significantly increased in SOMÀ/À mice stomachs. The SOMÀ/À mice fundi were hyperplastic due to increased parietal cell numbers. In addition to increased cell turnover, SOMÀ/À mice also showed an increased apoptotic rate. However, the increase in apoptosis appeared to be These data are not surprising given the antiproliferative and apoptotic effects of RUNX3 (Li et al., 2002; Torquati et al., 2004 ). In the current study, gross and microscopic evidence of proliferation and cellular atypia were strongly suggestive of malignancy, as has been described in other studies (Wang et al., 2000; Fox et al., 2003) . Histologic examination of the human gastric mucosa is the most accepted method for assessing malignancy in the stomach. Indeed, studies of the mouse gastric mucosa have suggested the presence of malignancy based on histologic evaluation (Wang et al., 2000; Fox et al., 2003) . However, even with histological evaluation, there has been no assay used in mouse models to confirm the presence of a transformed phenotype, which may be important due to hyperplasia induced by inflammation. Since the definitive diagnosis of neoplastic transformation requires evidence of functional cell alterations (i.e. loss of growth control) in addition to evidence of morphologic alteration, we performed an anchorageindependent growth assay with the mouse tumor cells. Functional transformation assays are particularly useful when inflammation is also present, because inflammatory mediators can induce morphologic changes in cells (atypia) making it difficult to distinguish from neoplasia by light microscopy alone. A novel feature of the study described here is that we supported our histologic diagnosis of neoplastic transformation by using a functional assay. Furthermore, the ability to isolate these tumors from mice will permit development of novel mouse gastric cell lines available for future molecular studies.
Materials and methods
Animals
Wild-type (WT C57BL/6, n ¼ 10), gastrin-deficient (GÀ/À 129/Sv crossed with C57BL/6, n ¼ 10) and somatostatindeficient (SOMÀ/À C57BL/6, n ¼ 10) mice were maintained in individual, sterile microisolator cages in nonbarrier mouse rooms (conventional housing) for 12 months. After 12 months, the mice were fasted, then killed prior to analysis of gastric physiology. The study was performed with the approval of the University of Michigan Animal Care and Use Committee that maintains an American Association of Assessment and Accreditation of Laboratory Animal Care (AAALAC) facility.
Immunohistochemistry and immunofluorescence
A longitudinal section of the stomach (spanning both the fundic and antral regions) was fixed in 4% paraformaldehyde/ PBS, paraffin-embedded and 3 mm sections were prepared. Antigen retrieval was performed after deparaffinization by heating the slides for 10 min at 1001C in 0.01 M sodium citrate. Nonspecific antigenic sites were blocked with 20% normal Figure 9 IFNg expression in the WT, SOMÀ/À, GÀ/À metaplastic (GÀ/ÀM) and tumor (GÀ/ÀT) tissue. Quantitative RT-PCR was performed on total stomach RNA. The ratio of IFNg to GAPDH mRNA in WT, SOMÀ/À, GÀ/ÀM and GÀ/ÀT mice is shown. Data are shown as the mean7s.e.m., *Po0.05 versus WT, n ¼ 10 per group except n ¼ 4 for GÀ/ÀM and n ¼ 6 for GÀ/ÀT groups goat serum/PBS, 0.1% Triton X-100 for 30 min before incubating for 1 h in a 1 : 50 dilution of rabbit anti-MUC2 or anti-villin (Santa Cruz Biotechnology), or 1 : 1000 dilution of rabbit anti-STAT3 (Cell Signaling) at 41C overnight. Proliferation was assessed by staining sections using a 1 : 100 dilution of mouse anti-Ki67 (Phamingen). A 1 : 500 dilution of anti-goat, rabbit or mouse-IgG (Amersham Biosciences) was added for 30 min, and then visualized with avidin-biotin complexes using the Vectastain Elite ABC Kit using diaminobenzidine (DAB) as the substrate (Vector Laboratories, Inc., Burlingame, CA, USA). Apoptosis was assessed using an In Situ Cell Death Detection Kit (1 684 795, Roche) according to the manufacturer's specifications. Sections were also stained for parietal and gastrin-expressing cells. After permeabilizing with 3% H 2 O 2 and 100% ethanol, blocked sections were incubated for 2 h with a 1 : 200 dilution of mouse anti-H þ ,K þ -ATPase b subunit (Medical and Biological, Nagoya, Japan) or a 1 : 800 dilution of rabbit anti-gastrin (Dako Corporation, Carpentiria, CA, USA). A 1 : 200 dilution of either anti-mouse IgG conjugated to Texas Red or anti-rabbit IgG conjugated to FITC (Jackson Laboratories) was used as the secondary antibody to detect the mouse or rabbit primary antibodies, respectively. The number of Ki67, apoptotic (TUNEL), H þ , K þ -ATPase and gastrin-stained cells was quantified by morphometry and expressed as the average number of cells counted per gland. A total of 10 oriented glands in random fields was counted for each mouse.
Sections stained by H&E were examined for the presence of mucous gland metaplasia and tumors by a pathologist blinded to the experimental design (Eaton et al., 1999) . Mucous gland metaplasia was confirmed by the presence of intestinal mucins with PAS/alcian blue, pH 2.5. Briefly, each microscopic field was scored for the presence or absence of two categories of inflammatory cells -either neutrophils (PMN) or mononuclear inflammatory cells that include lymphocytes, plasma cells or histocytes (LPH). The results were expressed as a percentage of the total number of fields in the section. Inflammation was further quantified by immunostaining the stomach sections with a 1 : 200 dilution of a rat monoclonal CD4 antibody (Santa Cruz Biotechnology). Immunostained cells were visualized using the anti-mouse Vectastain Elite ABC Kit (Vector Laboratories, Inc., Burlingame, CA, USA) as described above. Since most of the inflammation was in the antrum, antralpositive CD4 cells were counted in 10 high-power fields of the antrum ( Â 400). Each high-power field was equivalent to approximately 100 epithelial cells. Therefore, the results were expressed as CD4 þ cells/100 epithelial cells (Zavros et al., 2003) . Mucous gland metaplasia was confirmed by the presence of intestinal mucins with PAS/alcian blue, pH 2.5.
Gastrin radioimmunoassay (RIA)
After killing, approximately 1 ml of blood was collected by cardiac puncture, aliquoted into lithium-heparin tubes (SAR-STEDT, Germany) and centrifuged at 15 000 r.p.m. for 15 min at 41C. Plasma was collected immediately and stored at À201C until assayed for gastrin by RIA as previously described (Zavros et al., 2002b) .
Gastric acidity
In total, 2 ml of saline was used to rinse the stomach at the time of killing. Hydrogen ion concentration was determined by base titration with 0.005 N NaOH and expressed as mEq acid using a pH-STAT control titrator (PHM 290, Radiometer Analytical S.A., France).
Cell culture
The gastric cancer cell line, MKN45, was cultured in RPMI media supplemented with 5% fetal calf serum and 1% penicillin/streptomycin in 5% CO 2 at 371C. MKN45 cells were cocultured with either PBS, IFNg (100 nM), gastrin (10 nM) or IFNg plus gastrin for 6 h. After the 6 h incubation, cells were collected and whole-cell extracts prepared using M-PER reagent according to the manufacturer's protocol (Pierce). Briefly, the suspended cells were centrifuged at 2500 g for 10 min, the supernatant was discarded and the cells were washed with PBS. M-PER reagent was then added to the cell pellet, cell debris removed by centrifugation at 14 000g for 15 min and the supernatant removed into a new tube for analysis. Whole-cell extracts were kept at À801C until Western blot analysis.
Western blot analysis
Protein was extracted from stomachs removed from WT, GÀ/À and SOMÀ/À 12-month-old mice. After homogenizing the tissue in lysis buffer (300 mmol/l NaCl, 30 mmol/l Tris, 2 mmol/l MgCl 2 , 2 mmol/l CaCl 2 , 1% Triton X-100, pH 7.4) supplemented with protease inhibitors (Complete tablets, Roche), 100 mg of homogenate per lane was loaded on a 4-20% sodium dodecyl sulfate-polyacrylamide gradient gel (Invitrogen, Carlsbad, CA, USA) for immunoblot analysis.
The membranes were blocked with 0.5 Â Uniblock (Analytical Genetic Testing Center, Inc.) for 15 min at room temperature followed by an overnight incubation with a 1 : 500 dilution of the rabbit RUNX3 (Active Motif), phospho-STAT3 (Tyr 705), STAT3, STAT1 (Cell Signaling), phospho-ERK (Santa Cruz) or GAPDH (Chemicon) antibodies. The membranes were washed three times for 5 min and incubated for an additional 1 h with a 1 : 2000 dilution of either Alexa Fluor 680 goat anti-rabbit or anti-mouse IgG (Molecular Probes). Proteins were visualized using the Odyssey Infrared Imaging System (Li-Cor Biosciences, Nabraska, USA). Western blots were quantified using the Odyssey Infrared Imaging System software and data expressed pixels/mm 2 .
Quantitative RT-PCR (qRT-PCR)
Total RNA was isolated from stomach tissues of WT, SOMÀ/À, GÀ/ÀM and GÀ/ÀT mice using Trizol Reagent. PCR primers and fluorogenic probes for both IFNg and GAPDH genes were designed according to Overbergh et al. (1999) . The primer and probe sequences for IFNg were IFNg-probe: TCA CCA TCC TTT TGC CAG TTC CTC CAG; IFNg-reverse: TGG CTC TGC AGG ATT TTC ATG; IFNg-forward: TCA AGT GGC ATA GAT GTG GAA GAA. The primer and probe sequences for GAPDH were GAPDH-probe: TGC ATC CTG CAC CAC CAA CTG CTT AG; GAPDH-reverse: GGC ATG GAC TGT GGT CAT GA; GAPDH-forward: TTC ACC ACC ATG GAG AAG GC. The fluorogenic probes contained a reporter dye (FAM) covalently attached to the 5 0 end (Research Genetics Inc., Huntsville, AL, USA). The quencher dye (TAMRA) was attached to the 3 0 end (Research Genetics). PCR amplifications were performed in a total volume of 25 ml, containing 10 Â PCR buffer with MgCl 2 , 10 nM dNTPs, 200 nM of primers, 1 ml of cDNA Taq Polymerase Gold and Probe (100 nM) (Biorad Laboratories, I-Cycler IQ Real-Time PCR Detection System, Hercules, CA, USA). Each PCR amplification was performed in triplicate wells in a Biorad I-Cycler, using the following conditions: 501C for 2 min and 941C for 10 min, followed by 45 two-temperature cycles (941C for 15 s and 601C for 1 min). Fold change was calculated as (C t ÀC thigh ) ¼ n target , 2 ntarget /2 nGAPDH ¼ fold change,
Chronic gastritis in the gastrin-deficient mouse Y Zavros et al where C t ¼ threshold cycle. The results were expressed as a ratio of IFNg to GAPDH mRNA (fold change). cDNAs were also reverse transcribed from total RNA obtained from WT, GÀ/À and SOMÀ/À stomachs using an oligo-dT primer according to the manufacturer's protocol (GIBCO-BRL, Superscript kit). Primer pairs C97 and C98 were used to amplify the 16S rRNA species that is specific for Helicobacter and generates an amplicon of approximately 400 base pairs (Fox et al., 1998; Zavros et al., 2002a Zavros et al., , 2003 . To confirm the integrity of the prepared RNA, the same cDNAs were subjected to PCR amplification of GAPDH. The sense primer sequence for GAPDH was 5 0 -TTCACCACCATGGA-GAAGGC and 5 0 -GGCATGGACTGTGGTCATGA (antisense) (Invitrogen). PCR amplifications were performed in a total volume of 25 ml, containing 10 Â PCR buffer with MgCl 2 , 10 nM dNTPs, 200 nM primers, 5 ml of cDNA, 100 nM Taq Polymerase GOLD and 2.5 ml of Sybr Green (Molecular Probes). Each PCR amplification was performed in duplicate using the following conditions: 941C for 10 min, followed by 35 two-temperature cycles (941C for 1 min and 551C for 1 min). No 16S rRNA product was detected in all 30 mice studied verifying the absence of Helicobacter colonization (data not shown).
Anchorage-independence assay of isolated primary tumor cells
Cells from gastric tumors that arose in the GÀ/À mouse antrums and cells from histologically normal gastric mucosa from all three mouse groups were isolated according to a previously modified method using dispase (Zavros et al., 2002a) . The cells that were dissociated from the gastric tumors and an immortalized murine gastric mucous cell line (GSM06, donated from Dr Yoshiaki Tabuchi, Daiichi Pharmaceutical Co., Ltd, Tokyo, Japan) were cultured in DMEM containing 10% fetal calf serum, 2% penicillin-streptomycin antibiotic mixture, 1% ITSX (2 mg/l insulin, 2 mg/l transferrin, 0.122 mg/ l ethanolmine and 0.00914 mg/l sodium selenite) and 10 ng/ml murine epidermal growth factor (EGF) (Gibco/BRL Laboratories, Grand Island, NY, USA). A human gastric adenocarcinoma cell line (AGS, ATCC, Manassas, VA, USA) and a neoplastic gastric mucous line (NCI-N87, ATCC, Manassas, VA, USA) were grown in monolayers in T-75 tissue culture flasks in DMEM/10% fetal calf serum containing 1% penicillin-streptomycin antibiotic mixture (Gibco/BRL Laboratories, Grand Island, NY, USA). A total of 5000 cells in media were added to 0.6% agarose, and then 2 ml of the cellagarose mixture were added to 12-well plates. The cells were incubated for 14 days. The number of colonies/well for each cell line was then counted.
Statistical analysis
The significance of the results was tested using the unpaired ttest using a commercially available software (GraphPad Prism, GraphPad Software, San Diego, CA, USA). A Po0.05 was considered significant. Abbreviations WT, wild-type mice; GÀ/À, gastrin-deficient mice; SOMÀ/À, somatostatin-deficient; G cells, gastrin-expressing cells; H&E, hematoxylin and eosin; GÀ/ÀM, metaplastic tissue in gastrindeficient mice; GÀ/ÀT, tumor tissue in gastrin-deficient mice.
